Liquid Biopsy Testing Solution with NGS

Genes2me Pvt Ltd08 May, 2026Health

Liquid biopsy, combined with next-generation sequencing (NGS), is transforming cancer detection by enabling non-invasive analysis of circulating tumour DNA (ctDNA) from a simple blood sample. Unlike traditional screening and tissue biopsies, this approach offers higher sensitivity, early detection, and real-time disease monitoring. With advancements in NGS, liquid biopsy can detect cancer-related mutations at very low levels, supporting early diagnosis and personalised treatment decisions. Solutions like Genes2Me’s liquid biopsy panels are helping bring this innovation into routine clinical practice, improving outcomes through earlier and more precise intervention.

Automated Next Generation Sequencing Data Analysis

Genes2me Pvt Ltd08 May, 2026Health

The true potential of genomics is unlocked not just by generating data, but by understanding it. With the right combination of automation and intelligent analysis, diagnostics becomes faster, clearer, and more impactful. That’s the direction modern healthcare is heading—and it’s already within reach. Genes2me is not just advancing diagnostics-it is redefining the standard of care through precision, speed and clinical intelligence. From sequencing to saving lives-Genes2me turns data into decisive clinical impact.

Library Preparation System - Automated NGS Device

Genes2me Pvt Ltd08 May, 2026Health

In today’s fast-paced laboratory environment, manual NGS library preparation is no longer sustainable. The EZY AutoPrep-48 automated library preparation system provides a powerful solution by combining automation, precision, and scalability into a single compact platform. Whether you are scaling your sequencing capabilities or improving workflow efficiency, EZY AutoPrep-48 enables you to deliver high-quality genomic data faster and more reliably.

Comprehensive RT-PCR Approach to Culture-free Sepsis and AMR Detection

Genes2me Pvt Ltd08 May, 2026Health

Sepsis and antimicrobial resistance (AMR) together form a high-stakes intersection of infectious disease and global health. Delays in diagnosis translate directly into increased mortality, longer hospital stays, and greater antibiotic misuse. The development of integrated, high-throughput, closed-system molecular assays capable of detecting both sepsis pathogens and key AMR genes, including from whole blood in under two hours, signals a meaningful step forward. As healthcare systems confront rising resistance and persistent sepsis burden, comprehensive molecular diagnostics will play an increasingly central role. The ability to move from days to hours in actionable results may not only improve patient outcomes but also strengthen antimicrobial management efforts worldwide.

Advanced molecular diagnostics - targeted NGS are transforming TB diagnosis

Genes2me Pvt Ltd08 May, 2026Health

Tuberculosis remains a major global health burden, increasingly complicated by rising drug-resistant forms such as MDR and XDR-TB. While conventional diagnostics play a key role, they often fall short in detecting resistance early. Advanced molecular diagnostics, including real-time PCR, point-of-care systems, and targeted NGS are transforming TB diagnosis by enabling faster detection, comprehensive resistance profiling, and more effective, timely treatment decisions. tuberculosis, molecular diagnostics solutions, poct, point of care testing, poc solution, ngs, ngs solutions, rt-pcr, rt-pcr solution, drug resistant, drug resistant tuberculosis, tb solution, tb diagnosis

Advanced Real Time PCR system

Genes2me Pvt Ltd26 Feb, 2025Health

The RapiCycler 96 is a High-Performance Real-Time PCR Instrument meticulously engineered to cater to the demands of high-end laboratories. Equipped with 4 or 6 fluorescence channels, this advanced system can process up to 96 samples simultaneously. Boasting a wide array of applications, the RapiCycler 96 supports qualitative and quantitative analysis, absolute and relative quantitation, melting curve analysis, standard curve and dissociation curve analysis, multiplex PCR, SNP genotyping, HRM, allele identification, and a temperature gradient function. Leveraging cutting-edge semiconductor technology, the instrument rapidly executes the PCR amplification process. At the same time its high-sensitivity photoelectric detection system ensures real-time fluorescence signal monitoring, which is then analyzed and processed by robust software, delivering accurate and reliable results.

Point of Care Testing Solution - Fully Automated Detection System

Genes2me Pvt Ltd26 Feb, 2025Health

Point-of-care testing (POCT) revolutionizes clinical diagnostics by providing rapid and accurate diagnostic information at the patient's bedside. This advancement, driven by technologies like the miniaturization of medical devices, enables swift decision-making and treatment initiation. G2M is at the forefront of pioneering POCT solutions such as the OnePCR, Rapi-Q/Rapi-Q HT, and Rapi-X16 systems. These innovations offer high accuracy, quick turnaround times, and user-friendly features, enhancing patient care and clinical outcomes. G2M is leading the way in efficient, accurate, and accessible diagnostics poct, point of care testing, ngs, fully automated detection system, diagnostics solution, clinical solutions, poct solutions, g2m

COVID-19 Detection RT-PCR Kits

Genes2me Pvt Ltd26 Feb, 2025Health

Coronavirus referred to as Covid-19, is an infectious disease that affects the human respiratory system and makes breathing challenging. The COVID-19 pandemic posed an unparalleled threat to human life and resulted in a horrific worldwide death toll. Various high-quality SARS-CoV-2 (COVID-19) and Omicron variant in vitro detection kits are available at Genes2Me. These RT-PCR kits have no cross-reactivity with other pathogens and are highly compatible with widely accessible real-time PCR instruments. Call Now for Booking at [email protected]

Reproductive Health Testing RT-PCR Kits

Genes2me Pvt Ltd26 Feb, 2025Health

Disorders of the reproductive system are a growing problem that has a big impact on people all over the world. These problems include those that affect the reproductive system and have negative outcomes like infertility or difficult pregnancies. These conditions include a wide spectrum, including testicular, prostate, and menstruation diseases, as well as polycystic ovary syndrome, reproductive tract infections, and polycystic ovary syndrome. A wide range of CE-IVD-approved tests are available at Genes2Me with a high sensitivity that is conducive to producing the most accurate results. Call Now for Booking at [email protected]

A Fully Automated Detection System with Seamless Sample-to-Result Efficiency

Genes2me Pvt Ltd25 Feb, 2025Health

G2M introduces OnePCR, a fully automated detection system that transforms point-of-care testing with streamlined sample-to-result processing. Integrating nucleic acid extraction and real-time PCR in a single device reduces manual handling, minimizes human errors, and delivers contamination-free diagnostics. It can detect up to 20 targets from a single sample, utilizing magnetic bead-based extraction and five-channel fluorescence detection within pre-filled sealed cartridges for effortless and efficient workflows. Compact and user-friendly, OnePCR is designed for easy operation by semiskilled personnel.

Recent Profiles

daily islamic dua

Daily Islamic Dua

View Profile

Nhà Cái 7m

Nhà Cái 7m

View Profile

nhà cái uk88

Nhà Cái Uk88

View Profile

Hargatoto Situs Toto Togel

Hargatoto Situs Toto Togel

View Profile

aminatesa

Aminatesa

View Profile

Vebotv rip

Vebotv Rip

View Profile

Peeyush Sharma

Peeyush Sharma

View Profile

Rikbett cocom

Rikbett Cocom

View Profile

male stripper

Male Stripper

View Profile